{ "schemaVersion": "deck-intelligence.v1", "id": "019dd923-5ca1-7489-b638-229be117d58e", "slug": "415e33cb189c4261", "title": "Impact of the US BIOSECURE Act on Biopharmas, Contract Services and Investors", "subtitle": "L.E.K.", "author": "L.E.K.", "pageCount": 13, "kind": "consulting-deck", "orientation": "landscape", "aspectRatio": 1.778, "document": { "id": "019dd923-5ca1-7489-b638-229be117d58e", "slug": "415e33cb189c4261", "title": "Impact of the US BIOSECURE Act on Biopharmas, Contract Services and Investors", "rawTitle": "Impact of the US BIOSECURE Act on Biopharmas, Contract Services and Investors", "authorId": "LEK", "authorName": "L.E.K.", "authorDisplay": "L.E.K.", "kind": { "slug": "consulting-deck", "label": "Consulting deck" }, "sourceType": { "slug": "strategy_consulting", "label": "Strategy consulting" }, "fileName": "Impact-of-the-US-BIOSECURE-Act-on-Biopharmas-Contract-Services-and-Investors.pdf", "sourceUrl": "https://www.lek.com/sites/default/files/PDFs/impact-us-biosecure.pdf", "sourceDate": "2024-07-02 00:00:00", "presentationDate": null, "ingestedAt": "2026-04-23 20:51:37+00", "status": "ready", "pageCount": 13, "orientation": "landscape", "aspectRatio": 1.778, "targetCompany": null, "targetTicker": null, "metadata": { "local_root": "/tmp/legacy-images/415e33cb189c4261", "origin_corpus": "consulting" } }, "coverage": { "pageCount": 13, "pagesIndexed": 13, "pagesWithImages": 13, "pagesWithMetadata": 13, "imageCoveragePct": 100, "metadataCoveragePct": 100, "componentCount": 71, "chartCount": 6, "metricSlides": 6, "toolMatches": 1, "documentToolMatches": 0, "frameworkMatches": 2, "arcMatches": 1, "beatMatches": 4, "loopMatches": 1, "patternMatches": 0, "storymakersMatch": false, "scoreAvailable": true, "reviewAvailable": true, "activistThesisAvailable": false, "pitchdeckMetadataAvailable": false, "pitchdeckProfileAvailable": false }, "blocks": [], "matches": { "arcs": [ { "arc": { "name": "The Consultant's Gambit", "slug": "consultants-gambit", "status": "active", "bestFor": "Business cases, project proposals, strategic recommendations", "canonId": "019dd956-5e0a-73c8-b305-81c38c959e9c", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Situation & Context -> Problem & Complication -> Solution & Approach -> Evidence & Proof -> Impact & Next Steps", "description": null, "familyLabel": null, "categoryName": "Strategy & Business", "categorySlug": "strategy-business" }, "matchId": "382efbae-e1f6-4e39-8b56-a2b69643d386", "evidence": "The document follows a typical consulting deck structure, with situation/context, problem/complication, and solution/approach", "isPrimary": true, "confidence": 0.8, "extraction": { "at": "2026-07-16 21:06:12.798333+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "beats": [ { "to": 3, "arc": { "name": "The Consultant's Gambit", "slug": "consultants-gambit", "status": "active", "bestFor": "Business cases, project proposals, strategic recommendations", "canonId": "019dd956-5e0a-73c8-b305-81c38c959e9c", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Situation & Context -> Problem & Complication -> Solution & Approach -> Evidence & Proof -> Impact & Next Steps", "description": null, "familyLabel": null, "categoryName": "Strategy & Business", "categorySlug": "strategy-business" }, "from": 1, "name": "Situation & Context", "beatId": "f0590932-f4ae-46a3-a1a6-5e805bd8a9eb", "matchId": "382efbae-e1f6-4e39-8b56-a2b69643d386", "beatType": { "name": "Situation & Context", "slug": "consultants-gambit-situation-context", "status": "active", "canonId": "019dd9b8-05ae-741b-992d-65ee83c639b3", "version": 1, "description": null }, "evidence": "The document provides an overview of the US BIOSECURE Act and its context", "position": 0, "isPrimaryArc": true, "parentBeatType": { "name": "Setup", "slug": "setup", "status": "active", "canonId": "019dd9b8-020e-7505-af9b-d9b9a4679bcc", "version": 1, "description": "Where the deck grounds the reader before doing anything else. Almost every arc opens here." }, "alignedBlockIds": null, "matchConfidence": 0.8 }, { "to": 5, "arc": { "name": "The Consultant's Gambit", "slug": "consultants-gambit", "status": "active", "bestFor": "Business cases, project proposals, strategic recommendations", "canonId": "019dd956-5e0a-73c8-b305-81c38c959e9c", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Situation & Context -> Problem & Complication -> Solution & Approach -> Evidence & Proof -> Impact & Next Steps", "description": null, "familyLabel": null, "categoryName": "Strategy & Business", "categorySlug": "strategy-business" }, "from": 4, "name": "Problem & Complication", "beatId": "62cb5ef7-b2aa-470b-9a14-de03e71a4028", "matchId": "382efbae-e1f6-4e39-8b56-a2b69643d386", "beatType": { "name": "Problem & Complication", "slug": "consultants-gambit-problem-complication", "status": "active", "canonId": "019dd9b8-064a-777f-a374-e9a8c43dedd4", "version": 1, "description": null }, "evidence": "The document highlights the potential impact of the Act on biopharmas and contract services", "position": 1, "isPrimaryArc": true, "parentBeatType": { "name": "Complication", "slug": "complication", "status": "active", "canonId": "019dd9b8-0275-7709-b2d6-4f77c3fc7579", "version": 1, "description": "The point in the narrative where the audience should feel discomfort. Required for argumentative arcs." }, "alignedBlockIds": null, "matchConfidence": 0.8 }, { "to": 10, "arc": { "name": "The Consultant's Gambit", "slug": "consultants-gambit", "status": "active", "bestFor": "Business cases, project proposals, strategic recommendations", "canonId": "019dd956-5e0a-73c8-b305-81c38c959e9c", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Situation & Context -> Problem & Complication -> Solution & Approach -> Evidence & Proof -> Impact & Next Steps", "description": null, "familyLabel": null, "categoryName": "Strategy & Business", "categorySlug": "strategy-business" }, "from": 6, "name": "Evidence & Proof", "beatId": "f22e8876-c901-4ea3-b100-be2f21d5e929", "matchId": "382efbae-e1f6-4e39-8b56-a2b69643d386", "beatType": { "name": "Evidence & Proof", "slug": "consultants-gambit-evidence-proof", "status": "active", "canonId": "019dd9b8-07b1-7688-8e1e-7637fec3802a", "version": 1, "description": null }, "evidence": "The document presents data and findings from L.E.K.'s survey", "position": 2, "isPrimaryArc": true, "parentBeatType": { "name": "Evidence", "slug": "evidence", "status": "active", "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a", "version": 1, "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development." }, "alignedBlockIds": null, "matchConfidence": 0.8 }, { "to": 12, "arc": { "name": "The Consultant's Gambit", "slug": "consultants-gambit", "status": "active", "bestFor": "Business cases, project proposals, strategic recommendations", "canonId": "019dd956-5e0a-73c8-b305-81c38c959e9c", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Situation & Context -> Problem & Complication -> Solution & Approach -> Evidence & Proof -> Impact & Next Steps", "description": null, "familyLabel": null, "categoryName": "Strategy & Business", "categorySlug": "strategy-business" }, "from": 11, "name": "Impact & Next Steps", "beatId": "0238f363-ad64-4a16-9a67-df99117320f1", "matchId": "382efbae-e1f6-4e39-8b56-a2b69643d386", "beatType": { "name": "Impact & Next Steps", "slug": "consultants-gambit-impact-next-steps", "status": "active", "canonId": "019dd9b8-0849-7728-9ee9-fd1609c4c655", "version": 1, "description": null }, "evidence": "The document provides insights into strategic adjustments and future implications", "position": 3, "isPrimaryArc": true, "parentBeatType": { "name": "Resolution", "slug": "resolution", "status": "active", "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b", "version": 1, "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution." }, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [ { "to": 10, "from": 4, "loop": { "name": "27_cost_of_inaction", "slug": "27-cost-of-inaction", "status": "active", "bestFor": "Urgent budget requests, compliance, risk mitigation", "canonId": "019dd956-70d1-7395-a15b-857ba858b394", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "description": "Quantify what happens if the audience does nothing", "familyLabel": null, "categoryName": "Urgency", "categorySlug": "urgency" }, "matchId": "04a5278d-7e5b-4b55-a8c7-0de1c16bfa6b", "evidence": "The document presents data on the potential impact of the Act on partnerships with Chinese companies", "position": 0, "objective": "Highlighting the consequences of not adapting to the US BIOSECURE Act", "confidence": 0.6, "extraction": { "at": "2026-07-16 21:06:12.966727+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "tools": [ { "tool": { "name": "Slide recipe: Cover", "slug": "cover-slide", "status": "active", "bestFor": null, "canonId": "019df269-2a08-767d-9128-e7431e6fe8a3", "version": 1, "bodyDocId": "019df269-29e5-7738-b5fa-6892e5dc8e65", "description": "The first ten seconds. Build it deliberately.", "familyLabel": "slide-recipe", "categoryName": "Slide", "categorySlug": "slide" }, "agent": "designer", "layer": "slide", "agents": [ "designer" ], "matchId": "df5b674c-e45e-4358-b47e-d4e71b9b453d", "evidence": "This is a cover slide with a title and subtitle.", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.9, "extraction": { "at": "2026-07-16 21:13:37.729485+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 1, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null } ], "frameworks": [ { "matchId": "907a4fe3-56ab-4d96-876a-762db0bd40d2", "evidence": "The slide uses a horizontal timeline to map legislative events over time.", "framework": null, "confidence": 0.8, "extraction": { "at": "2026-05-02 19:25:18.877+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 3, "frameworkName": "gantt-chart" }, { "matchId": "bcca2b77-d455-46c8-9f7f-80175a5986b3", "evidence": "The slide maps vertical industry sectors against horizontal functional capabilities.", "framework": null, "confidence": 0.8, "extraction": { "at": "2026-05-02 19:25:18.597+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 11, "frameworkName": "value-chain" } ], "patterns": [] }, "storymakers": null, "score": { "backend": "codex", "scoredAt": "2026-05-02 17:14:47.309+00", "subScores": { "scqa_arc": 58, "action_titles": 82, "mece_structure": 62, "closing_strength": 45, "evidence_quality": 84, "clarity_of_thesis": 75, "production_quality": 76, "visual_storytelling": 78 }, "totalScore": 70, "coveragePct": 100, "explanations": { "scqa_arc": "Slides 2-4 establish situation and complication, and slides 5-10 answer with survey findings, but the implied question is not made explicit and the story reads partly as an analytical dump.", "action_titles": "Most analytical pages use insight-bearing titles, e.g. slide 7: \"Many are reconsidering their partnerships with Chinese companies; however, only a small number have taken actual steps to unwind these relationships.\"", "mece_structure": "The deck separates context, impact, behavior, and stakeholder cuts, but slides 6-10 overlap across confidence, reconsideration, adjustments, and interest without a fully exhaustive audience/action architecture.", "closing_strength": "The deck ends with a firm profile, contact page, and disclaimer on slides 11-13 rather than a clear recommendation, decision, or sequenced next steps.", "evidence_quality": "Claims are mostly backed by survey data, charted cuts, and percentage callouts on slides 2 and 6-10, with slide 4 adding external BIO survey evidence.", "clarity_of_thesis": "The central argument is identifiable by slides 4-5: BIOSECURE may push diversification away from China, but industry action remains cautious and uneven.", "production_quality": "Branding, footnotes, and chart discipline are strong, but long action titles and dense/overcrowded pages such as slides 2 and 6-10 reduce whitespace and executive readability.", "visual_storytelling": "The deck generally matches message to format with timelines, callouts, icon lists, and segmented bar charts on slides 2-10, though several dense survey charts carry more detail than a single crisp takeaway." }, "slidesAnalyzed": 13 }, "review": { "backend": null, "verdict": "A competent, quant-anchored survey readout with strong declarative titles in the middle, but it sells its own findings short by ending in a capabilities pitch instead of a recommendation - use slides 7-8 as examples of insight-bearing titles, not the overall structure as a Storymakers exemplar.", "reviewedAt": "2026-04-25 02:11:49+00", "slidesSeen": 13, "suggestions": [ "Add a 'So what' slide after p.10 with 2-3 explicit recommendations segmented by audience (biopharma, CxO, investor) - the p.8 stakeholder split already sets up the structure for this", "Collapse p.5 and p.9 into a single Key Findings slide on page 2 (lead with the answer) and redeploy the freed slot to a recommendation or scenario timeline", "Insert a section divider before p.6 stating the MECE cut of the findings (e.g., 'Sentiment -> Intent -> Action -> Stakeholder'), so the analytical run reads as an argument, not a topic dump" ], "closingScore": 32, "openingScore": 62, "topStrengths": [ "Contrast-laden action titles in the analytical core (p.7 reconsidering-vs-acting, p.8 biopharma-vs-investor split) do real argumentative work rather than just labelling charts", "Quantified callouts under each slide (79% have Chinese CDMO contracts p.4, 68% adjusting actions p.5) ground every claim in survey numbers", "Tight 13-page format forces discipline - the context section is only two slides before the findings begin" ], "topWeaknesses": [ "No Resolution act: the deck ends on a capabilities slide (p.11) and a sales CTA (p.12) instead of a recommendation for biopharmas, CxOs or investors", "Repetition between p.5 and p.9 - both lead with the same '68% of life sciences companies are adjusting...' statistic with near-identical phrasing, which wastes a slide in a 13-page deck", "Middle section (p.6-10) has no MECE spine - five consecutive 'market_landscape' findings with no divider to signal the cut (confidence -> intent -> action -> stakeholder -> use-case)", "Opening buries the lead: the thesis on supply-chain diversification only appears on p.4, and the punchline on behavioral inertia ('reconsidering but not acting') is hidden on p.7" ], "narrativeScore": 58, "pillarCritique": "No visible section dividers or MECE pillars - slides 6-10 are a topic dump all tagged market_landscape/industry_trends, so the analytical middle reads as a list of findings rather than a structured cut (e.g., by stakeholder x action x timing).", "closingCritique": "There is no recommendation or next-steps slide: the analytical run ends at p.10, then p.11 is an L.E.K. credentials page and p.12 is literally 'Connect with us'. A reader closes the deck knowing what the survey found but not what they should do about it.", "openingCritique": "The first three slides (cover plus two context slides) establish the Act and the survey but never front-load the punchline; the thesis only surfaces on p.4-5, so the opening informs rather than hooks. P.5's 'Key findings' action title does pull double duty as a mini-answer, which partially rescues the build.", "extractionSeconds": 65.63825, "narrativeCritique": "The deck has a recognizable S->C->A arc (context on the Act p.2-3, disruption framing p.4, survey findings p.5-10) but no Resolution act - it pivots straight from data to an L.E.K. capabilities slide and 'Connect with us', leaving the reader without a 'so what' or recommended response.", "titleQualityScore": 74, "titleQualityCritique": "Most middle titles are genuinely declarative and insight-bearing - e.g. p.7 'Many are reconsidering their partnerships...however, only a small number have taken actual steps' and p.8 'Biopharmas and CxOs are directly impacted, while most investors adopt a wait-and-see attitude'. The back-matter drops into topic labels ('Connect with us', the L.E.K. capabilities header), weakening the overall average." }, "activistThesis": null, "pitchdeck": { "metadata": null, "profile": null }, "slides": [ { "page": 1, "type": "setup", "function": "front_matter", "imagePath": "https://imgproxy.kitesheet.com/0uWTOrruUOOSwPTy9wAniem1B8y4cPyZ9i1CxN9Sd30/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy80MTVlMzNjYjE4OWM0MjYxL3AwMDEuanBn", "rawType": "cover", "block": null, "metadata": { "slideType": "cover", "slideTypeCanon": { "name": "Cover", "slug": "cover", "status": "active", "canonId": "019de52d-05f2-729d-9f93-e0504f0a2410", "version": 1, "description": null }, "function": "front_matter", "functionCanon": { "name": "Front matter", "slug": "front_matter", "status": "active", "canonId": "019de52d-133d-73f0-9e26-201eda96b098", "version": 1, "description": null }, "density": "balanced", "densityScore": 29, "componentCount": 5, "textChars": 339, "nDataPoints": 0, "notes": null, "elementsJson": [ "logo_grid", "photo" ], "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 19:25:16.438+00", "seconds": 2.403, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-5ca1-7489-b638-229be117d58e/1", "deck": "/decks/019dd923-5ca1-7489-b638-229be117d58e", "deckAnchor": "/decks/019dd923-5ca1-7489-b638-229be117d58e#slide-1", "deckJson": "/decks/019dd923-5ca1-7489-b638-229be117d58e.json" }, "components": [ { "bbox": { "h": 0.05, "w": 0.35, "x": 0.037, "y": 0.902 }, "kind": "disclaimer", "text": "These materials are intended to supplement a discussion with L.E.K. Consulting. The contents of the materials are confidential and subject to obligations of non-disclosure. Your attention is drawn to the full disclaimer contained in this document.", "attrs": null, "canon": { "kind": { "name": "Disclaimer", "slug": "disclaimer", "status": "active", "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc", "version": 1, "description": "Legal/cautionary text that occupies most of the body of its slide." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:16.438+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "71600261-0fa1-4ad9-a22b-06063ad11f43", "parentComponentId": null }, { "bbox": { "h": 0.045, "w": 0.08, "x": 0.037, "y": 0.065 }, "kind": "image", "text": "LEK", "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Logo", "slug": "logo", "status": "active", "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302", "version": 1, "description": null }, "framework": null }, "subkind": "logo", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:16.438+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "bff9d94b-85e9-4149-9b65-ddf9d449a35e", "parentComponentId": null }, { "bbox": { "h": 0.83, "w": 0.5, "x": 0.5, "y": 0.17 }, "kind": "image", "text": null, "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Photo", "slug": "photo", "status": "active", "canonId": "019de52c-fd37-757f-b4a8-ca26d4888875", "version": 1, "description": null }, "framework": null }, "subkind": "photo", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:16.438+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "956c6a14-69ec-443d-a21b-90e5b3a01946", "parentComponentId": null }, { "bbox": { "h": 0.03, "w": 0.1, "x": 0.037, "y": 0.605 }, "kind": "paragraph", "text": "July 2, 2024", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:16.438+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "226c699a-19ca-4a36-b6fe-80bd1e465ff9", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.4, "x": 0.037, "y": 0.355 }, "kind": "title", "text": "Impact of the US BIOSECURE Act on Biopharmas, Contract Services and Investors", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:16.438+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "9bada13b-6e9e-4af8-896a-d14280e7e048", "parentComponentId": null } ], "metrics": [], "tools": [ { "tool": { "name": "Slide recipe: Cover", "slug": "cover-slide", "status": "active", "bestFor": null, "canonId": "019df269-2a08-767d-9128-e7431e6fe8a3", "version": 1, "bodyDocId": "019df269-29e5-7738-b5fa-6892e5dc8e65", "description": "The first ten seconds. Build it deliberately.", "familyLabel": "slide-recipe", "categoryName": "Slide", "categorySlug": "slide" }, "agent": "designer", "layer": "slide", "agents": [ "designer" ], "matchId": "df5b674c-e45e-4358-b47e-d4e71b9b453d", "evidence": "This is a cover slide with a title and subtitle.", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.9, "extraction": { "at": "2026-07-16 21:13:37.729485+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 1, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null } ], "frameworks": [], "arcBeats": [ { "to": 3, "arc": { "name": "The Consultant's Gambit", "slug": "consultants-gambit", "status": "active", "bestFor": "Business cases, project proposals, strategic recommendations", "canonId": "019dd956-5e0a-73c8-b305-81c38c959e9c", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Situation & Context -> Problem & Complication -> Solution & Approach -> Evidence & Proof -> Impact & Next Steps", "description": null, "familyLabel": null }, "from": 1, "name": "Situation & Context", "beatId": "f0590932-f4ae-46a3-a1a6-5e805bd8a9eb", "matchId": "382efbae-e1f6-4e39-8b56-a2b69643d386", "beatType": { "name": "Situation & Context", "slug": "consultants-gambit-situation-context", "status": "active", "canonId": "019dd9b8-05ae-741b-992d-65ee83c639b3", "version": 1, "description": null }, "evidence": "The document provides an overview of the US BIOSECURE Act and its context", "position": 0, "isPrimaryArc": true, "parentBeatType": { "name": "Setup", "slug": "setup", "status": "active", "canonId": "019dd9b8-020e-7505-af9b-d9b9a4679bcc", "version": 1, "description": "Where the deck grounds the reader before doing anything else. Almost every arc opens here." }, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [], "thumbSrc": "https://imgproxy.kitesheet.com/eYPtx6EaXTy9syUc9yb5JRoyjcrfhniyqs7D18oMH4g/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy80MTVlMzNjYjE4OWM0MjYxL3AwMDEuanBn", "imagePathAlt": "https://imgproxy.kitesheet.com/IpEkc_o8l8LCfSsz-Wx0GCuLyFNU4xxhvEs50h5U2Xg/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy80MTVlMzNjYjE4OWM0MjYxL3AwMDEucG5n", "thumbSrcAlt": "https://imgproxy.kitesheet.com/JknEiOO1Dn-zAXkGGaAfwcBzkYE9RXfTnNqdXT3ItO4/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy80MTVlMzNjYjE4OWM0MjYxL3AwMDEucG5n" }, { "page": 2, "type": "setup", "title": "The slide provides a methodological overview of the survey sample, including familiarity, geography, sector, and functional role of respondents.", "function": "establish_context", "rawType": "appendix_methodology", "block": null, "metadata": { "slideType": "appendix_methodology", "slideTypeCanon": { "name": "Appendix methodology", "slug": "appendix_methodology", "status": "active", "canonId": "019de52d-07d9-726c-8599-167f2d2ffaa7", "version": 1, "description": null }, "function": "establish_context", "functionCanon": { "name": "Establish context", "slug": "establish_context", "status": "active", "canonId": "019de52d-1314-74e6-9074-d213dc0bdcdf", "version": 1, "description": null }, "density": "dense", "densityScore": 67, "componentCount": 6, "textChars": 1230, "nDataPoints": 16, "notes": "The slide provides a methodological overview of the survey sample, including familiarity, geography, sector, and functional role of respondents.", "elementsJson": [ "headline_text", "callout_box", "bar_chart_stacked", "footnote" ], "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 19:25:16.949+00", "seconds": 2.86, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-5ca1-7489-b638-229be117d58e/2", "deck": "/decks/019dd923-5ca1-7489-b638-229be117d58e", "deckAnchor": "/decks/019dd923-5ca1-7489-b638-229be117d58e#slide-2", "deckJson": "/decks/019dd923-5ca1-7489-b638-229be117d58e.json" }, "components": [ { "bbox": null, "kind": "callout", "text": "The US BIOSECURE Act, introduced in Dec. 2023, proposes to prohibit federal contracting with biotechnology providers connected to foreign adversaries.", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": { "name": "Visual emphasis", "slug": "visual-emphasis", "status": "active", "bestFor": null, "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c", "version": 1, "bodyDocId": null, "description": "Drawing the eye to one element above the rest of the slide.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-24 13:18:20+00", "model": "or:google/gemini-3.1-flash-lite-preview", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd951-c7ca-701b-9cc5-5b9907424219", "parentComponentId": null }, { "bbox": { "h": 0.65, "w": 0.64, "x": 0.32, "y": 0.21 }, "kind": "chart", "text": "L.E.K. Global Survey on Impact of the US BIOSECURE Act Respondent Mix (June 2024)", "attrs": null, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Stacked bar chart", "slug": "bar-stacked", "status": "active", "canonId": "019de52c-feec-74bf-9028-15b74f84f0a7", "version": 1, "description": null }, "framework": null }, "subkind": "bar-stacked", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:16.949+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "d6f755fa-835c-42cf-b9db-faad7b6b7be7", "parentComponentId": null }, { "bbox": null, "kind": "metric", "text": "Respondent mix: 73", "attrs": null, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": { "name": "Quantification", "slug": "quantification", "status": "active", "bestFor": null, "canonId": "019dd9e1-47ab-72ce-a079-aab1f5299e88", "version": 1, "bodyDocId": null, "description": "Translating a claim into numbers, charts, or tables.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": "primary", "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-24 13:18:20+00", "model": "or:google/gemini-3.1-flash-lite-preview", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd951-c7ca-701b-9cc5-5c89423e9147", "parentComponentId": null }, { "bbox": { "h": 0.65, "w": 0.25, "x": 0.04, "y": 0.21 }, "kind": "paragraph", "text": "Background\nThe US BIOSECURE Act, introduced in Dec. 2023, proposes to prohibit federal contracting with biotechnology providers connected to foreign adversaries\nIf this goes into effect, it will impact any company that does (or wants to) receive US federal government contracts (i.e., most global pharma companies), and restrict them from partnering with companies of concern, including certain Chinese CROs/CDMOs\nTo understand the sentiments and reactions, L.E.K. conducted a proprietary survey among global life sciences companies\nAt the time of publication of this report, the US BIOSECURE Act had not been passed", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:16.949+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "a6f3ad70-9a9a-4bb9-a241-35418181cdc1", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.5, "x": 0.04, "y": 0.88 }, "kind": "source-note", "text": "Note: Total of 73 responses; CRO=contract research organization; CDMO=contract development manufacture organization\nSource: L.E.K. 2024 Global Survey on Impact of US BIOSECURE Act", "attrs": null, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:16.949+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "e090f1c0-c417-432c-b629-d6d9106be158", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.94, "x": 0.03, "y": 0.06 }, "kind": "title", "text": "L.E.K. Consulting conducted a survey on the impact of the US BIOSECURE Act; this June 2024 study engaged respondents across different biopharma and services sectors familiar with the Act", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:16.949+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "719e3a22-808b-4264-94c8-a251cddcc901", "parentComponentId": null } ], "metrics": [ { "metricRaw": "Respondent mix", "numberRaw": "73", "numberKind": "plain", "actionTitle": "L.E.K. Consulting conducted a survey on the impact of the US BIOSECURE Act; this June 2024 study engaged respondents across different biopharma and services sectors familiar with the Act", "calloutText": "The US BIOSECURE Act, introduced in Dec. 2023, proposes to prohibit federal contracting with biotechnology providers connected to foreign adversaries.", "numberScale": null, "numberValue": 73, "metricFamily": "survey_sentiment", "numberCurrency": null } ], "tools": [], "frameworks": [], "arcBeats": [ { "to": 3, "arc": { "name": "The Consultant's Gambit", "slug": "consultants-gambit", "status": "active", "bestFor": "Business cases, project proposals, strategic recommendations", "canonId": "019dd956-5e0a-73c8-b305-81c38c959e9c", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Situation & Context -> Problem & Complication -> Solution & Approach -> Evidence & Proof -> Impact & Next Steps", "description": null, "familyLabel": null }, "from": 1, "name": "Situation & Context", "beatId": "f0590932-f4ae-46a3-a1a6-5e805bd8a9eb", "matchId": "382efbae-e1f6-4e39-8b56-a2b69643d386", "beatType": { "name": "Situation & Context", "slug": "consultants-gambit-situation-context", "status": "active", "canonId": "019dd9b8-05ae-741b-992d-65ee83c639b3", "version": 1, "description": null }, "evidence": "The document provides an overview of the US BIOSECURE Act and its context", "position": 0, "isPrimaryArc": true, "parentBeatType": { "name": "Setup", "slug": "setup", "status": "active", "canonId": "019dd9b8-020e-7505-af9b-d9b9a4679bcc", "version": 1, "description": "Where the deck grounds the reader before doing anything else. Almost every arc opens here." }, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [], "locked": true }, { "page": 3, "type": "setup", "title": "The slide highlights the timing of an L.E.K. survey relative to the legislative process.", "function": "establish_context", "rawType": "timeline", "block": null, "metadata": { "slideType": "timeline", "slideTypeCanon": { "name": "Timeline", "slug": "timeline", "status": "active", "canonId": "019de52d-0851-75eb-b758-ea2965e7739a", "version": 1, "description": null }, "function": "establish_context", "functionCanon": { "name": "Establish context", "slug": "establish_context", "status": "active", "canonId": "019de52d-1314-74e6-9074-d213dc0bdcdf", "version": 1, "description": null }, "density": "sparse", "densityScore": 15, "componentCount": 3, "textChars": 264, "nDataPoints": 0, "notes": "The slide highlights the timing of an L.E.K. survey relative to the legislative process.", "elementsJson": [ "headline_text", "timeline_visual" ], "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 19:25:18.877+00", "seconds": 4.705, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-5ca1-7489-b638-229be117d58e/3", "deck": "/decks/019dd923-5ca1-7489-b638-229be117d58e", "deckAnchor": "/decks/019dd923-5ca1-7489-b638-229be117d58e#slide-3", "deckJson": "/decks/019dd923-5ca1-7489-b638-229be117d58e.json" }, "components": [ { "bbox": { "h": 0.65, "w": 0.94, "x": 0.03, "y": 0.22 }, "kind": "diagram", "text": "Timeline of the US BIOSECURE Act", "attrs": null, "canon": { "kind": { "name": "Diagram", "slug": "diagram", "status": "active", "canonId": "019de52c-f9f0-734a-81de-15382ff28c65", "version": 1, "description": "Schematic or relational diagram." }, "tool": null, "subkind": { "name": "Timeline", "slug": "timeline", "status": "active", "canonId": "019de52d-03c5-73fc-84aa-4180cbf0f5cf", "version": 1, "description": null }, "framework": null }, "subkind": "timeline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:18.877+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "d5091faf-14fa-41e7-9820-a8911a2c0eb7", "parentComponentId": null }, { "bbox": { "h": 0.02, "w": 0.15, "x": 0.03, "y": 0.91 }, "kind": "source-note", "text": "Source: US Congress, L.E.K. analysis", "attrs": null, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:18.877+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "4bad16e3-5c41-4e87-9718-48b71c1a5d7f", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.94, "x": 0.03, "y": 0.06 }, "kind": "title", "text": "L.E.K.'s survey was conducted after a draft of the BIOSECURE Act was approved by the House Oversight Committee; the full congressional approval and signing into law is not expected before year end", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:18.877+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "f9071c4a-4298-45e1-99a2-c526ecdcd8f4", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [ { "matchId": "907a4fe3-56ab-4d96-876a-762db0bd40d2", "evidence": "The slide uses a horizontal timeline to map legislative events over time.", "framework": null, "confidence": 0.8, "extraction": { "at": "2026-05-02 19:25:18.877+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 3, "frameworkName": "gantt-chart" } ], "arcBeats": [ { "to": 3, "arc": { "name": "The Consultant's Gambit", "slug": "consultants-gambit", "status": "active", "bestFor": "Business cases, project proposals, strategic recommendations", "canonId": "019dd956-5e0a-73c8-b305-81c38c959e9c", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Situation & Context -> Problem & Complication -> Solution & Approach -> Evidence & Proof -> Impact & Next Steps", "description": null, "familyLabel": null }, "from": 1, "name": "Situation & Context", "beatId": "f0590932-f4ae-46a3-a1a6-5e805bd8a9eb", "matchId": "382efbae-e1f6-4e39-8b56-a2b69643d386", "beatType": { "name": "Situation & Context", "slug": "consultants-gambit-situation-context", "status": "active", "canonId": "019dd9b8-05ae-741b-992d-65ee83c639b3", "version": 1, "description": null }, "evidence": "The document provides an overview of the US BIOSECURE Act and its context", "position": 0, "isPrimaryArc": true, "parentBeatType": { "name": "Setup", "slug": "setup", "status": "active", "canonId": "019dd9b8-020e-7505-af9b-d9b9a4679bcc", "version": 1, "description": "Where the deck grounds the reader before doing anything else. Almost every arc opens here." }, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [], "locked": true }, { "page": 4, "type": "resolution", "function": "summarize", "rawType": "key_takeaways", "block": null, "metadata": { "slideType": "key_takeaways", "slideTypeCanon": { "name": "Key takeaways", "slug": "key_takeaways", "status": "active", "canonId": "019de52d-06e7-7674-a891-9f7de3b11b6d", "version": 1, "description": null }, "function": "summarize", "functionCanon": { "name": "Summarize", "slug": "summarize", "status": "active", "canonId": "019de52d-1541-704f-b86f-bf7b75056373", "version": 1, "description": null }, "density": "overcrowded", "densityScore": 90, "componentCount": 10, "textChars": 2124, "nDataPoints": 2, "notes": null, "elementsJson": [ "headline_text", "bullet_list", "icon_grid" ], "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 19:25:18.639+00", "seconds": 4.418, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-5ca1-7489-b638-229be117d58e/4", "deck": "/decks/019dd923-5ca1-7489-b638-229be117d58e", "deckAnchor": "/decks/019dd923-5ca1-7489-b638-229be117d58e#slide-4", "deckJson": "/decks/019dd923-5ca1-7489-b638-229be117d58e.json" }, "components": [ { "bbox": null, "kind": "callout", "text": "Seventy-nine percent of respondents to the BIO survey conducted in May 2024 reported that they have contracts or products being supported by a Chinese CDMO.", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": { "name": "Visual emphasis", "slug": "visual-emphasis", "status": "active", "bestFor": null, "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c", "version": 1, "bodyDocId": null, "description": "Drawing the eye to one element above the rest of the slide.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-24 13:18:20+00", "model": "or:google/gemini-3.1-flash-lite-preview", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd951-c7ca-701b-9cc5-3c047f3bc45f", "parentComponentId": null }, { "bbox": { "h": 0.22, "w": 0.32, "x": 0.038, "y": 0.21 }, "kind": "list", "text": "Decline in overseas upstream demand for Chinese suppliers", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:18.639+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "33aca505-cba9-4d15-a974-9352e4ac3622", "parentComponentId": null }, { "bbox": { "h": 0.12, "w": 0.32, "x": 0.038, "y": 0.47 }, "kind": "list", "text": "Increasing opportunities for ex-China suppliers", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:18.639+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "3ff78aff-6c4d-4139-a257-8ceb5e4cb012", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.32, "x": 0.038, "y": 0.625 }, "kind": "list", "text": "Challenges to pharma supply chain resilience, biotechs impacted to a larger extent", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:18.639+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "919a0e17-4590-4302-bff8-e42b1c47b4e0", "parentComponentId": null }, { "bbox": null, "kind": "metric", "text": "revenue: 65%", "attrs": null, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": { "name": "Quantification", "slug": "quantification", "status": "active", "bestFor": null, "canonId": "019dd9e1-47ab-72ce-a079-aab1f5299e88", "version": 1, "bodyDocId": null, "description": "Translating a claim into numbers, charts, or tables.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": "primary", "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-24 13:18:20+00", "model": "or:google/gemini-3.1-flash-lite-preview", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd951-c7ca-701b-9cc5-4036baa4e77e", "parentComponentId": null }, { "bbox": { "h": 0.12, "w": 0.58, "x": 0.38, "y": 0.47 }, "kind": "paragraph", "text": "Ex-China CRO/CDMOs could potentially benefit from the bill as pharmaceutical companies seek to diversify their production from the mentioned companies, or even from China. Contract organizations such as Evotec and Fujifilm Diosynth have reportedly been receiving increasing engagement and exploratory inquires.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:18.639+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "22ef7990-aa40-4b69-90ae-1fd77a689c1e", "parentComponentId": null }, { "bbox": { "h": 0.22, "w": 0.58, "x": 0.38, "y": 0.21 }, "kind": "paragraph", "text": "The current bill only explicitly listed five companies (WuXi Apptec, MGI, BGI, Complete Genomics and WuXi Biologics) and their affiliates. International demand accounts for a large portion of revenue for these companies (e.g., WuXi Apptec derived 65% of its 2023 revenue from US). This Act could potentially result in a remarkable decrease in upstream demand for the services provided by the named companies. In addition, this may affect more Chinese CRO/CDMOs in the future, given the uncertainty of the final legislation (e.g., which companies would be designated as biotechnology company of concern) and a halo effect beyond the mentioned companies.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:18.639+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "4a1f8de5-97ba-4221-932a-47a1cb971c1a", "parentComponentId": null }, { "bbox": { "h": 0.22, "w": 0.58, "x": 0.38, "y": 0.625 }, "kind": "paragraph", "text": "Seventy-nine percent of respondents to the BIO survey conducted in May 2024 reported that they have contracts or products being supported by a Chinese CDMO. Changing vendors could be challenging, time consuming and costly, especially considering the validation processes and regulatory approvals required. Both US and non-US biopharmaceutical companies have begun to explore mitigation plans and seek backup supplies. While established biopharmas often have more robust and resilient supply chain and manufacturing footprints, biotechs are expected to be impacted to a larger extent by a potential decoupling.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:18.639+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "9df85743-7a10-43b4-90a1-caaf27007760", "parentComponentId": null }, { "bbox": { "h": 0.03, "w": 0.25, "x": 0.038, "y": 0.9 }, "kind": "source-note", "text": "Source: Press release, L.E.K. research and analysis", "attrs": null, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:18.639+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "ac680203-deeb-453e-ba7a-72076070d264", "parentComponentId": null }, { "bbox": { "h": 0.13, "w": 0.92, "x": 0.038, "y": 0.06 }, "kind": "title", "text": "The US BIOSECURE Act may prompt pharma companies to diversify their supply chain away from China, creating more opportunities for ex-China suppliers", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:18.639+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "69f60f68-436b-481e-9f4f-7468bc8c052d", "parentComponentId": null } ], "metrics": [ { "metricRaw": "revenue", "numberRaw": "65%", "numberKind": "percent", "actionTitle": "The US BIOSECURE Act may prompt pharma companies to diversify their supply chain away from China, creating more opportunities for ex-China suppliers", "calloutText": "Seventy-nine percent of respondents to the BIO survey conducted in May 2024 reported that they have contracts or products being supported by a Chinese CDMO.", "numberScale": null, "numberValue": 65, "metricFamily": "revenue", "numberCurrency": null } ], "tools": [], "frameworks": [], "arcBeats": [ { "to": 5, "arc": { "name": "The Consultant's Gambit", "slug": "consultants-gambit", "status": "active", "bestFor": "Business cases, project proposals, strategic recommendations", "canonId": "019dd956-5e0a-73c8-b305-81c38c959e9c", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Situation & Context -> Problem & Complication -> Solution & Approach -> Evidence & Proof -> Impact & Next Steps", "description": null, "familyLabel": null }, "from": 4, "name": "Problem & Complication", "beatId": "62cb5ef7-b2aa-470b-9a14-de03e71a4028", "matchId": "382efbae-e1f6-4e39-8b56-a2b69643d386", "beatType": { "name": "Problem & Complication", "slug": "consultants-gambit-problem-complication", "status": "active", "canonId": "019dd9b8-064a-777f-a374-e9a8c43dedd4", "version": 1, "description": null }, "evidence": "The document highlights the potential impact of the Act on biopharmas and contract services", "position": 1, "isPrimaryArc": true, "parentBeatType": { "name": "Complication", "slug": "complication", "status": "active", "canonId": "019dd9b8-0275-7709-b2d6-4f77c3fc7579", "version": 1, "description": "The point in the narrative where the audience should feel discomfort. Required for argumentative arcs." }, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [ { "to": 10, "from": 4, "loop": { "name": "27_cost_of_inaction", "slug": "27-cost-of-inaction", "status": "active", "bestFor": "Urgent budget requests, compliance, risk mitigation", "canonId": "019dd956-70d1-7395-a15b-857ba858b394", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "description": "Quantify what happens if the audience does nothing", "familyLabel": null }, "matchId": "04a5278d-7e5b-4b55-a8c7-0de1c16bfa6b", "evidence": "The document presents data on the potential impact of the Act on partnerships with Chinese companies", "position": 0, "objective": "Highlighting the consequences of not adapting to the US BIOSECURE Act", "confidence": 0.6, "extraction": { "at": "2026-07-16 21:06:12.966727+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 5, "type": "resolution", "function": "summarize", "rawType": "key_takeaways", "block": null, "metadata": { "slideType": "key_takeaways", "slideTypeCanon": { "name": "Key takeaways", "slug": "key_takeaways", "status": "active", "canonId": "019de52d-06e7-7674-a891-9f7de3b11b6d", "version": 1, "description": null }, "function": "summarize", "functionCanon": { "name": "Summarize", "slug": "summarize", "status": "active", "canonId": "019de52d-1541-704f-b86f-bf7b75056373", "version": 1, "description": null }, "density": "overcrowded", "densityScore": 83, "componentCount": 8, "textChars": 1803, "nDataPoints": 10, "notes": null, "elementsJson": [ "headline_text", "icon_grid", "bullet_list" ], "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 19:25:17.85+00", "seconds": 3.515, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-5ca1-7489-b638-229be117d58e/5", "deck": "/decks/019dd923-5ca1-7489-b638-229be117d58e", "deckAnchor": "/decks/019dd923-5ca1-7489-b638-229be117d58e#slide-5", "deckJson": "/decks/019dd923-5ca1-7489-b638-229be117d58e.json" }, "components": [ { "bbox": null, "kind": "callout", "text": "Sixty-eight percent of the life sciences companies are adjusting their actions, including increasing legal and compliance requirements, diversifying partnerships and adding background checks for existing partners.", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": { "name": "Visual emphasis", "slug": "visual-emphasis", "status": "active", "bestFor": null, "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c", "version": 1, "bodyDocId": null, "description": "Drawing the eye to one element above the rest of the slide.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-24 13:18:21+00", "model": "or:google/gemini-3.1-flash-lite-preview", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd951-c7ca-701b-9cc5-df259e9c6410", "parentComponentId": null }, { "bbox": { "h": 0.7, "w": 0.25, "x": 0.05, "y": 0.2 }, "kind": "image", "text": null, "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Icon grid", "slug": "icon-grid", "status": "active", "canonId": "019de52c-fdfe-749d-9990-1db465a3eed4", "version": 1, "description": null }, "framework": null }, "subkind": "icon-grid", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:17.85+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "8dce27ca-6c9b-471c-b217-f4cff0c4121d", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.6, "x": 0.35, "y": 0.2 }, "kind": "list", "text": "Confidence in working with Chinese companies has dropped by 30-50% for US-based life sciences companies, with CDMOs being the worst hit. Those outside of the US are also concerned, though much less so (20-30% decrease in confidence level).", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:17.85+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "6d0094a1-2b13-4564-aacd-9e722c785c15", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.6, "x": 0.35, "y": 0.72 }, "kind": "list", "text": "Amid the US-China biotechnology decoupling threats, the majority of the biopharma still show high interest to partner with Chinese companies for product commercialization. Collaboration with Chinese service providers in clinical research, development and manufacturing are also not completely off the table, with approximately 30% of respondents considering these partnerships as likely in the next three years.", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:17.85+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "8fdfb23e-8606-452b-99dd-06027b241066", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.6, "x": 0.35, "y": 0.55 }, "kind": "list", "text": "Sixty-eight percent of the life sciences companies are adjusting their actions, including increasing legal and compliance requirements, diversifying partnerships and adding background checks for existing partners. Few companies (13%) based in Asia (ex-China) are actively considering diversifying partnerships to other countries; however, background checks for existing partners are frequently reported (38%).", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:17.85+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "aa86c135-21e0-4776-a3ca-feefcc2a2310", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.6, "x": 0.35, "y": 0.38 }, "kind": "list", "text": "Twenty-six percent of the life sciences companies are looking to shift away from their current Chinese partners. Only 2%, however, have taken actual steps to unwind relationships with companies named in the US BIOSECURE Act. Still 11% of the life sciences companies report no impact on their partnership decisions.", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:17.85+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "ff245b8c-1336-4769-9911-26c18f09a4d6", "parentComponentId": null }, { "bbox": null, "kind": "metric", "text": "Confidence level: 68%", "attrs": null, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": { "name": "Quantification", "slug": "quantification", "status": "active", "bestFor": null, "canonId": "019dd9e1-47ab-72ce-a079-aab1f5299e88", "version": 1, "bodyDocId": null, "description": "Translating a claim into numbers, charts, or tables.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": "primary", "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-24 13:18:21+00", "model": "or:google/gemini-3.1-flash-lite-preview", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd951-c7ca-701b-9cc5-e2a758e0af9e", "parentComponentId": null }, { "bbox": { "h": 0.1, "w": 0.9, "x": 0.05, "y": 0.05 }, "kind": "title", "text": "Key findings of L.E.K.'s 2024 Global Survey on Impact of the US BIOSECURE Act suggests that industry has started to take precautionary measures, but many remain keen to work with Chinese companies", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:17.85+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "c5302ebb-e6cc-42ab-a544-7df86421b1f2", "parentComponentId": null } ], "metrics": [ { "metricRaw": "Confidence level", "numberRaw": "68%", "numberKind": "percent", "actionTitle": "Key findings of L.E.K.'s 2024 Global Survey on Impact of the US BIOSECURE Act suggests that industry has started to take precautionary measures, but many remain keen to work with Chinese companies", "calloutText": "Sixty-eight percent of the life sciences companies are adjusting their actions, including increasing legal and compliance requirements, diversifying partnerships and adding background checks for existing partners.", "numberScale": null, "numberValue": 68, "metricFamily": "index_score", "numberCurrency": null } ], "tools": [], "frameworks": [], "arcBeats": [ { "to": 5, "arc": { "name": "The Consultant's Gambit", "slug": "consultants-gambit", "status": "active", "bestFor": "Business cases, project proposals, strategic recommendations", "canonId": "019dd956-5e0a-73c8-b305-81c38c959e9c", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Situation & Context -> Problem & Complication -> Solution & Approach -> Evidence & Proof -> Impact & Next Steps", "description": null, "familyLabel": null }, "from": 4, "name": "Problem & Complication", "beatId": "62cb5ef7-b2aa-470b-9a14-de03e71a4028", "matchId": "382efbae-e1f6-4e39-8b56-a2b69643d386", "beatType": { "name": "Problem & Complication", "slug": "consultants-gambit-problem-complication", "status": "active", "canonId": "019dd9b8-064a-777f-a374-e9a8c43dedd4", "version": 1, "description": null }, "evidence": "The document highlights the potential impact of the Act on biopharmas and contract services", "position": 1, "isPrimaryArc": true, "parentBeatType": { "name": "Complication", "slug": "complication", "status": "active", "canonId": "019dd9b8-0275-7709-b2d6-4f77c3fc7579", "version": 1, "description": "The point in the narrative where the audience should feel discomfort. Required for argumentative arcs." }, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [ { "to": 10, "from": 4, "loop": { "name": "27_cost_of_inaction", "slug": "27-cost-of-inaction", "status": "active", "bestFor": "Urgent budget requests, compliance, risk mitigation", "canonId": "019dd956-70d1-7395-a15b-857ba858b394", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "description": "Quantify what happens if the audience does nothing", "familyLabel": null }, "matchId": "04a5278d-7e5b-4b55-a8c7-0de1c16bfa6b", "evidence": "The document presents data on the potential impact of the Act on partnerships with Chinese companies", "position": 0, "objective": "Highlighting the consequences of not adapting to the US BIOSECURE Act", "confidence": 0.6, "extraction": { "at": "2026-07-16 21:06:12.966727+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 6, "type": "analysis", "title": "The chart uses a grouped bar format to compare 'Before' and 'After' confidence scores (0-10 scale) with percentage change annotations.", "function": "analyze_data", "rawType": "data_table", "block": null, "metadata": { "slideType": "data_table", "slideTypeCanon": { "name": "Data table", "slug": "data_table", "status": "active", "canonId": "019de52d-0bbd-71b9-9918-417f904abbf8", "version": 1, "description": null }, "function": "analyze_data", "functionCanon": { "name": "Analyze data", "slug": "analyze_data", "status": "active", "canonId": "019de52d-1590-7413-8c82-cc218cff40b4", "version": 1, "description": null }, "density": "balanced", "densityScore": 47, "componentCount": 5, "textChars": 585, "nDataPoints": 18, "notes": "The chart uses a grouped bar format to compare 'Before' and 'After' confidence scores (0-10 scale) with percentage change annotations.", "elementsJson": [ "headline_text", "bar_chart_grouped", "footnote" ], "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 19:25:17.413+00", "seconds": 2.832, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-5ca1-7489-b638-229be117d58e/6", "deck": "/decks/019dd923-5ca1-7489-b638-229be117d58e", "deckAnchor": "/decks/019dd923-5ca1-7489-b638-229be117d58e#slide-6", "deckJson": "/decks/019dd923-5ca1-7489-b638-229be117d58e.json" }, "components": [ { "bbox": { "h": 0.6, "w": 0.92, "x": 0.04, "y": 0.25 }, "kind": "chart", "text": "Grouped bar chart showing confidence levels across All geographies, US, and Asia ex-China for CROs, CDMOs, and Biopharmas.", "attrs": null, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Grouped bar chart", "slug": "bar-grouped", "status": "active", "canonId": "019de52c-ff3b-751e-a8ff-f21ff11097b1", "version": 1, "description": null }, "framework": null }, "subkind": "bar-grouped", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:17.413+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "b82c5c3c-da97-43cb-abe6-f3ff4cf1da7e", "parentComponentId": null }, { "bbox": { "h": 0.04, "w": 0.6, "x": 0.04, "y": 0.89 }, "kind": "disclaimer", "text": "*Survey question: Select, on a scale of 0 to 10, your confidence level on partnering with Chinese companies (0 is extremely low and 10 is extremely high). Source: L.E.K. 2024 Global Survey on Impact of US BIOSECURE Act", "attrs": null, "canon": { "kind": { "name": "Disclaimer", "slug": "disclaimer", "status": "active", "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc", "version": 1, "description": "Legal/cautionary text that occupies most of the body of its slide." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:17.413+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "98e74b26-c325-4c15-8bb7-e4e39d5b1b2b", "parentComponentId": null }, { "bbox": { "h": 0.03, "w": 0.35, "x": 0.58, "y": 0.26 }, "kind": "legend", "text": "Before introduction of the Act; After introduction of the Act", "attrs": null, "canon": { "kind": { "name": "Legend", "slug": "legend", "status": "active", "canonId": "31361933-3d22-4c70-bbad-0801e9fffc0c", "version": 1, "description": "Color/symbol decoder placed adjacent to a chart or diagram." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:17.413+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "bdcc6baa-c5af-4a21-8510-7d7032b21c7c", "parentComponentId": null }, { "bbox": null, "kind": "metric", "text": "Confidence level (0-10 scale)", "attrs": null, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": { "name": "Quantification", "slug": "quantification", "status": "active", "bestFor": null, "canonId": "019dd9e1-47ab-72ce-a079-aab1f5299e88", "version": 1, "bodyDocId": null, "description": "Translating a claim into numbers, charts, or tables.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": "primary", "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-24 13:18:26+00", "model": "or:google/gemini-3.1-flash-lite-preview", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd951-c7ca-701b-9cc6-4049a918f182", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.94, "x": 0.03, "y": 0.06 }, "kind": "title", "text": "Overall confidence level on partnering with Chinese companies has decreased after the introduction of the US BIOSECURE Act, especially among US respondents", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Action title", "slug": "action-title", "status": "active", "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d", "version": 1, "description": null }, "framework": null }, "subkind": "action-title", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:17.413+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "976e1bfa-1fed-4a2f-ab11-d7f129c1dd1e", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [ { "to": 10, "arc": { "name": "The Consultant's Gambit", "slug": "consultants-gambit", "status": "active", "bestFor": "Business cases, project proposals, strategic recommendations", "canonId": "019dd956-5e0a-73c8-b305-81c38c959e9c", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Situation & Context -> Problem & Complication -> Solution & Approach -> Evidence & Proof -> Impact & Next Steps", "description": null, "familyLabel": null }, "from": 6, "name": "Evidence & Proof", "beatId": "f22e8876-c901-4ea3-b100-be2f21d5e929", "matchId": "382efbae-e1f6-4e39-8b56-a2b69643d386", "beatType": { "name": "Evidence & Proof", "slug": "consultants-gambit-evidence-proof", "status": "active", "canonId": "019dd9b8-07b1-7688-8e1e-7637fec3802a", "version": 1, "description": null }, "evidence": "The document presents data and findings from L.E.K.'s survey", "position": 2, "isPrimaryArc": true, "parentBeatType": { "name": "Evidence", "slug": "evidence", "status": "active", "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a", "version": 1, "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development." }, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [ { "to": 10, "from": 4, "loop": { "name": "27_cost_of_inaction", "slug": "27-cost-of-inaction", "status": "active", "bestFor": "Urgent budget requests, compliance, risk mitigation", "canonId": "019dd956-70d1-7395-a15b-857ba858b394", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "description": "Quantify what happens if the audience does nothing", "familyLabel": null }, "matchId": "04a5278d-7e5b-4b55-a8c7-0de1c16bfa6b", "evidence": "The document presents data on the potential impact of the Act on partnerships with Chinese companies", "position": 0, "objective": "Highlighting the consequences of not adapting to the US BIOSECURE Act", "confidence": 0.6, "extraction": { "at": "2026-07-16 21:06:12.966727+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 7, "type": "analysis", "title": "The chart uses a multi-select survey format, so percentages may not sum to 100%.", "function": "analyze_data", "rawType": "data_table", "block": null, "metadata": { "slideType": "data_table", "slideTypeCanon": { "name": "Data table", "slug": "data_table", "status": "active", "canonId": "019de52d-0bbd-71b9-9918-417f904abbf8", "version": 1, "description": null }, "function": "analyze_data", "functionCanon": { "name": "Analyze data", "slug": "analyze_data", "status": "active", "canonId": "019de52d-1590-7413-8c82-cc218cff40b4", "version": 1, "description": null }, "density": "balanced", "densityScore": 45, "componentCount": 5, "textChars": 506, "nDataPoints": 24, "notes": "The chart uses a multi-select survey format, so percentages may not sum to 100%.", "elementsJson": [ "headline_text", "bar_chart_horizontal", "footnote" ], "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 19:25:17.347+00", "seconds": 2.416, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-5ca1-7489-b638-229be117d58e/7", "deck": "/decks/019dd923-5ca1-7489-b638-229be117d58e", "deckAnchor": "/decks/019dd923-5ca1-7489-b638-229be117d58e#slide-7", "deckJson": "/decks/019dd923-5ca1-7489-b638-229be117d58e.json" }, "components": [ { "bbox": { "h": 0.6, "w": 0.91, "x": 0.046, "y": 0.28 }, "kind": "chart", "text": "Grouped horizontal bar chart showing survey responses for Overall, US, and Asia (ex-China) regions.", "attrs": null, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Horizontal bar chart", "slug": "bar-horizontal", "status": "active", "canonId": "019de52c-fec4-7221-986b-1cb5f5e84b1f", "version": 1, "description": null }, "framework": null }, "subkind": "bar-horizontal", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:17.347+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "ca8749f9-2c5f-4fb3-95fd-aaa9e6837fb6", "parentComponentId": null }, { "bbox": null, "kind": "metric", "text": "Percentage of respondents: 2%", "attrs": null, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": { "name": "Quantification", "slug": "quantification", "status": "active", "bestFor": null, "canonId": "019dd9e1-47ab-72ce-a079-aab1f5299e88", "version": 1, "bodyDocId": null, "description": "Translating a claim into numbers, charts, or tables.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": "primary", "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-24 13:18:23+00", "model": "or:google/gemini-3.1-flash-lite-preview", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd951-c7ca-701b-9cc6-28631f8a2e61", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.5, "x": 0.038, "y": 0.89 }, "kind": "source-note", "text": "*Survey question: Has the BIOSECURE Act impacted your company's current operations? Select those which apply (Multi-select)\nSource: L.E.K. 2024 Global Survey on Impact of US BIOSECURE Act", "attrs": null, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:17.347+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "c4bcacf3-ab57-4596-b343-7627b73b66ec", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.92, "x": 0.038, "y": 0.06 }, "kind": "title", "text": "Many are reconsidering their partnerships with Chinese companies; however, only a small number have taken actual steps to unwind these relationships", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:17.347+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "bd6b7608-6462-4ea2-8154-ac38ce8537a1", "parentComponentId": null }, { "bbox": { "h": 0.03, "w": 0.35, "x": 0.046, "y": 0.22 }, "kind": "title", "text": "BIOSECURE Act impact on current operations*", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Subtitle", "slug": "subtitle", "status": "active", "canonId": "019de52c-fb09-739d-900c-815b0d9ac526", "version": 1, "description": null }, "framework": null }, "subkind": "subtitle", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:17.347+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "df158386-716a-4dd9-b766-822947fb0258", "parentComponentId": null } ], "metrics": [ { "metricRaw": "Percentage of respondents", "numberRaw": "2%", "numberKind": "percent", "actionTitle": "Many are reconsidering their partnerships with Chinese companies; however, only a small number have taken actual steps to unwind these relationships", "calloutText": null, "numberScale": null, "numberValue": 2, "metricFamily": "survey_sentiment", "numberCurrency": null } ], "tools": [], "frameworks": [], "arcBeats": [ { "to": 10, "arc": { "name": "The Consultant's Gambit", "slug": "consultants-gambit", "status": "active", "bestFor": "Business cases, project proposals, strategic recommendations", "canonId": "019dd956-5e0a-73c8-b305-81c38c959e9c", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Situation & Context -> Problem & Complication -> Solution & Approach -> Evidence & Proof -> Impact & Next Steps", "description": null, "familyLabel": null }, "from": 6, "name": "Evidence & Proof", "beatId": "f22e8876-c901-4ea3-b100-be2f21d5e929", "matchId": "382efbae-e1f6-4e39-8b56-a2b69643d386", "beatType": { "name": "Evidence & Proof", "slug": "consultants-gambit-evidence-proof", "status": "active", "canonId": "019dd9b8-07b1-7688-8e1e-7637fec3802a", "version": 1, "description": null }, "evidence": "The document presents data and findings from L.E.K.'s survey", "position": 2, "isPrimaryArc": true, "parentBeatType": { "name": "Evidence", "slug": "evidence", "status": "active", "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a", "version": 1, "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development." }, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [ { "to": 10, "from": 4, "loop": { "name": "27_cost_of_inaction", "slug": "27-cost-of-inaction", "status": "active", "bestFor": "Urgent budget requests, compliance, risk mitigation", "canonId": "019dd956-70d1-7395-a15b-857ba858b394", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "description": "Quantify what happens if the audience does nothing", "familyLabel": null }, "matchId": "04a5278d-7e5b-4b55-a8c7-0de1c16bfa6b", "evidence": "The document presents data on the potential impact of the Act on partnerships with Chinese companies", "position": 0, "objective": "Highlighting the consequences of not adapting to the US BIOSECURE Act", "confidence": 0.6, "extraction": { "at": "2026-07-16 21:06:12.966727+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 8, "type": "analysis", "title": "The chart uses a custom layout with a central axis and directional arrows to indicate sentiment/impact.", "function": "analyze_data", "rawType": "data_table", "block": null, "metadata": { "slideType": "data_table", "slideTypeCanon": { "name": "Data table", "slug": "data_table", "status": "active", "canonId": "019de52d-0bbd-71b9-9918-417f904abbf8", "version": 1, "description": null }, "function": "analyze_data", "functionCanon": { "name": "Analyze data", "slug": "analyze_data", "status": "active", "canonId": "019de52d-1590-7413-8c82-cc218cff40b4", "version": 1, "description": null }, "density": "balanced", "densityScore": 41, "componentCount": 5, "textChars": 430, "nDataPoints": 18, "notes": "The chart uses a custom layout with a central axis and directional arrows to indicate sentiment/impact.", "elementsJson": [ "headline_text", "bar_chart_horizontal", "footnote" ], "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 19:25:18.284+00", "seconds": 3.132, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-5ca1-7489-b638-229be117d58e/8", "deck": "/decks/019dd923-5ca1-7489-b638-229be117d58e", "deckAnchor": "/decks/019dd923-5ca1-7489-b638-229be117d58e#slide-8", "deckJson": "/decks/019dd923-5ca1-7489-b638-229be117d58e.json" }, "components": [ { "bbox": { "h": 0.62, "w": 0.91, "x": 0.046, "y": 0.27 }, "kind": "chart", "text": "Grouped horizontal bar chart showing survey responses across three segments", "attrs": null, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Horizontal bar chart", "slug": "bar-horizontal", "status": "active", "canonId": "019de52c-fec4-7221-986b-1cb5f5e84b1f", "version": 1, "description": null }, "framework": null }, "subkind": "bar-horizontal", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:18.284+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "42092486-99a4-4956-b2e9-5c5f4e17e521", "parentComponentId": null }, { "bbox": null, "kind": "metric", "text": "Percentage of respondents: 50%", "attrs": null, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": { "name": "Quantification", "slug": "quantification", "status": "active", "bestFor": null, "canonId": "019dd9e1-47ab-72ce-a079-aab1f5299e88", "version": 1, "bodyDocId": null, "description": "Translating a claim into numbers, charts, or tables.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": "primary", "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-24 13:18:21+00", "model": "or:google/gemini-3.1-flash-lite-preview", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd951-c7ca-701b-9cc5-c75cac39900e", "parentComponentId": null }, { "bbox": { "h": 0.04, "w": 0.52, "x": 0.038, "y": 0.885 }, "kind": "source-note", "text": "*Survey question: Has the BIOSECURE Act impacted your company's current operations? Select those which apply (Multi-select)\nSource: L.E.K. 2024 Global Survey on Impact of US BIOSECURE Act", "attrs": null, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:18.284+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "414930ae-296b-41ea-8813-cb6e2cebc2ca", "parentComponentId": null }, { "bbox": { "h": 0.035, "w": 0.897, "x": 0.038, "y": 0.105 }, "kind": "title", "text": "Biopharmas and CxOs are directly impacted, while most investors adopt a 'wait and see' attitude", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Action title", "slug": "action-title", "status": "active", "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d", "version": 1, "description": null }, "framework": null }, "subkind": "action-title", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:18.284+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "67933372-12c9-4e75-bbc2-8453b72fff39", "parentComponentId": null }, { "bbox": { "h": 0.025, "w": 0.35, "x": 0.046, "y": 0.223 }, "kind": "title", "text": "BIOSECURE Act impact on current operations*", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:18.284+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "f2b5902b-f35d-446c-a3f1-0995c7a90624", "parentComponentId": null } ], "metrics": [ { "metricRaw": "Percentage of respondents", "numberRaw": "50%", "numberKind": "percent", "actionTitle": "Biopharmas and CxOs are directly impacted, while most investors adopt a ‘wait and see’ attitude", "calloutText": null, "numberScale": null, "numberValue": 50, "metricFamily": "survey_sentiment", "numberCurrency": null } ], "tools": [], "frameworks": [], "arcBeats": [ { "to": 10, "arc": { "name": "The Consultant's Gambit", "slug": "consultants-gambit", "status": "active", "bestFor": "Business cases, project proposals, strategic recommendations", "canonId": "019dd956-5e0a-73c8-b305-81c38c959e9c", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Situation & Context -> Problem & Complication -> Solution & Approach -> Evidence & Proof -> Impact & Next Steps", "description": null, "familyLabel": null }, "from": 6, "name": "Evidence & Proof", "beatId": "f22e8876-c901-4ea3-b100-be2f21d5e929", "matchId": "382efbae-e1f6-4e39-8b56-a2b69643d386", "beatType": { "name": "Evidence & Proof", "slug": "consultants-gambit-evidence-proof", "status": "active", "canonId": "019dd9b8-07b1-7688-8e1e-7637fec3802a", "version": 1, "description": null }, "evidence": "The document presents data and findings from L.E.K.'s survey", "position": 2, "isPrimaryArc": true, "parentBeatType": { "name": "Evidence", "slug": "evidence", "status": "active", "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a", "version": 1, "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development." }, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [ { "to": 10, "from": 4, "loop": { "name": "27_cost_of_inaction", "slug": "27-cost-of-inaction", "status": "active", "bestFor": "Urgent budget requests, compliance, risk mitigation", "canonId": "019dd956-70d1-7395-a15b-857ba858b394", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "description": "Quantify what happens if the audience does nothing", "familyLabel": null }, "matchId": "04a5278d-7e5b-4b55-a8c7-0de1c16bfa6b", "evidence": "The document presents data on the potential impact of the Act on partnerships with Chinese companies", "position": 0, "objective": "Highlighting the consequences of not adapting to the US BIOSECURE Act", "confidence": 0.6, "extraction": { "at": "2026-07-16 21:06:12.966727+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 9, "type": "analysis", "title": "The chart displays multi-select survey data.", "function": "analyze_data", "rawType": "data_table", "block": null, "metadata": { "slideType": "data_table", "slideTypeCanon": { "name": "Data table", "slug": "data_table", "status": "active", "canonId": "019de52d-0bbd-71b9-9918-417f904abbf8", "version": 1, "description": null }, "function": "analyze_data", "functionCanon": { "name": "Analyze data", "slug": "analyze_data", "status": "active", "canonId": "019de52d-1590-7413-8c82-cc218cff40b4", "version": 1, "description": null }, "density": "balanced", "densityScore": 48, "componentCount": 5, "textChars": 606, "nDataPoints": 18, "notes": "The chart displays multi-select survey data.", "elementsJson": [ "headline_text", "bar_chart_horizontal", "footnote" ], "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 19:25:20.952+00", "seconds": 5.8, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-5ca1-7489-b638-229be117d58e/9", "deck": "/decks/019dd923-5ca1-7489-b638-229be117d58e", "deckAnchor": "/decks/019dd923-5ca1-7489-b638-229be117d58e#slide-9", "deckJson": "/decks/019dd923-5ca1-7489-b638-229be117d58e.json" }, "components": [ { "bbox": { "h": 0.55, "w": 0.92, "x": 0.04, "y": 0.32 }, "kind": "chart", "text": "Grouped horizontal bar chart showing survey responses for Overall, US, and Asia (ex-China) categories.", "attrs": null, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Horizontal bar chart", "slug": "bar-horizontal", "status": "active", "canonId": "019de52c-fec4-7221-986b-1cb5f5e84b1f", "version": 1, "description": null }, "framework": null }, "subkind": "bar-horizontal", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:20.952+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "519141f9-c646-4d05-829b-b3b7e6f068f4", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.65, "x": 0.03, "y": 0.89 }, "kind": "disclaimer", "text": "*Survey question: Has your company already made any strategic adjustments in response to the US BIOSECURE Act? Select those which apply (Multi-select)\nSource: L.E.K. 2024 Global Survey on Impact of US BIOSECURE Act", "attrs": null, "canon": { "kind": { "name": "Disclaimer", "slug": "disclaimer", "status": "active", "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc", "version": 1, "description": "Legal/cautionary text that occupies most of the body of its slide." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:20.952+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "c405dc0a-2085-4981-abd4-d3088ce672c3", "parentComponentId": null }, { "bbox": null, "kind": "metric", "text": "Percentage of respondents: 68%", "attrs": null, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": { "name": "Quantification", "slug": "quantification", "status": "active", "bestFor": null, "canonId": "019dd9e1-47ab-72ce-a079-aab1f5299e88", "version": 1, "bodyDocId": null, "description": "Translating a claim into numbers, charts, or tables.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": "primary", "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-24 13:18:21+00", "model": "or:google/gemini-3.1-flash-lite-preview", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd951-c7ca-701b-9cc5-99e28ecd80d3", "parentComponentId": null }, { "bbox": { "h": 0.12, "w": 0.94, "x": 0.03, "y": 0.06 }, "kind": "title", "text": "Sixty-eight percent of global life sciences companies have made strategic adjustments, including increasing legal and compliance requirements, diversifying partnerships and adding background checks", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Action title", "slug": "action-title", "status": "active", "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d", "version": 1, "description": null }, "framework": null }, "subkind": "action-title", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:20.952+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "b503fa56-9bcc-49ec-a15f-dae7ecb08b70", "parentComponentId": null }, { "bbox": { "h": 0.03, "w": 0.45, "x": 0.04, "y": 0.22 }, "kind": "title", "text": "Strategic adjustments made in response to the US BIOSECURE Act*", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:20.952+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "3a5b9239-37ad-439e-91cd-ba9a8978184b", "parentComponentId": null } ], "metrics": [ { "metricRaw": "Percentage of respondents", "numberRaw": "68%", "numberKind": "percent", "actionTitle": "Sixty-eight percent of global life sciences companies have made strategic adjustments, including increasing legal and compliance requirements, diversifying partnerships and adding background checks", "calloutText": null, "numberScale": null, "numberValue": 68, "metricFamily": "survey_sentiment", "numberCurrency": null } ], "tools": [], "frameworks": [], "arcBeats": [ { "to": 10, "arc": { "name": "The Consultant's Gambit", "slug": "consultants-gambit", "status": "active", "bestFor": "Business cases, project proposals, strategic recommendations", "canonId": "019dd956-5e0a-73c8-b305-81c38c959e9c", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Situation & Context -> Problem & Complication -> Solution & Approach -> Evidence & Proof -> Impact & Next Steps", "description": null, "familyLabel": null }, "from": 6, "name": "Evidence & Proof", "beatId": "f22e8876-c901-4ea3-b100-be2f21d5e929", "matchId": "382efbae-e1f6-4e39-8b56-a2b69643d386", "beatType": { "name": "Evidence & Proof", "slug": "consultants-gambit-evidence-proof", "status": "active", "canonId": "019dd9b8-07b1-7688-8e1e-7637fec3802a", "version": 1, "description": null }, "evidence": "The document presents data and findings from L.E.K.'s survey", "position": 2, "isPrimaryArc": true, "parentBeatType": { "name": "Evidence", "slug": "evidence", "status": "active", "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a", "version": 1, "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development." }, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [ { "to": 10, "from": 4, "loop": { "name": "27_cost_of_inaction", "slug": "27-cost-of-inaction", "status": "active", "bestFor": "Urgent budget requests, compliance, risk mitigation", "canonId": "019dd956-70d1-7395-a15b-857ba858b394", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "description": "Quantify what happens if the audience does nothing", "familyLabel": null }, "matchId": "04a5278d-7e5b-4b55-a8c7-0de1c16bfa6b", "evidence": "The document presents data on the potential impact of the Act on partnerships with Chinese companies", "position": 0, "objective": "Highlighting the consequences of not adapting to the US BIOSECURE Act", "confidence": 0.6, "extraction": { "at": "2026-07-16 21:06:12.966727+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 10, "type": "analysis", "title": "The chart displays survey results regarding the impact of the US BIOSECURE Act on partnering intentions.", "function": "analyze_data", "rawType": "data_table", "block": null, "metadata": { "slideType": "data_table", "slideTypeCanon": { "name": "Data table", "slug": "data_table", "status": "active", "canonId": "019de52d-0bbd-71b9-9918-417f904abbf8", "version": 1, "description": null }, "function": "analyze_data", "functionCanon": { "name": "Analyze data", "slug": "analyze_data", "status": "active", "canonId": "019de52d-1590-7413-8c82-cc218cff40b4", "version": 1, "description": null }, "density": "dense", "densityScore": 59, "componentCount": 6, "textChars": 681, "nDataPoints": 36, "notes": "The chart displays survey results regarding the impact of the US BIOSECURE Act on partnering intentions.", "elementsJson": [ "headline_text", "bar_chart_stacked", "footnote" ], "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 19:25:22.604+00", "seconds": 7.055, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-5ca1-7489-b638-229be117d58e/10", "deck": "/decks/019dd923-5ca1-7489-b638-229be117d58e", "deckAnchor": "/decks/019dd923-5ca1-7489-b638-229be117d58e#slide-10", "deckJson": "/decks/019dd923-5ca1-7489-b638-229be117d58e.json" }, "components": [ { "bbox": { "h": 0.55, "w": 0.92, "x": 0.038, "y": 0.3 }, "kind": "chart", "text": "Stacked bar chart showing likelihood of partnering across 3 regions and 4 categories", "attrs": null, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Stacked bar chart", "slug": "bar-stacked", "status": "active", "canonId": "019de52c-feec-74bf-9028-15b74f84f0a7", "version": 1, "description": null }, "framework": null }, "subkind": "bar-stacked", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:22.604+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "564ea094-574e-47d8-877c-798d20073474", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.5, "x": 0.038, "y": 0.88 }, "kind": "disclaimer", "text": "*Survey question: Select, on a scale of 0 to 10, your likelihood of partnering with Chinese companies (0 is extremely low and 10 is extremely high)\nSource: L.E.K. 2024 Global Survey on Impact of US BIOSECURE Act", "attrs": null, "canon": { "kind": { "name": "Disclaimer", "slug": "disclaimer", "status": "active", "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc", "version": 1, "description": "Legal/cautionary text that occupies most of the body of its slide." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:22.604+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "831eca13-bf28-46a3-8493-d3849447dfb4", "parentComponentId": null }, { "bbox": { "h": 0.04, "w": 0.55, "x": 0.41, "y": 0.83 }, "kind": "legend", "text": "Likely (selected 7-10) | Neither likely nor unlikely (selected 4-6) | Unlikely (selected 0-3)", "attrs": null, "canon": { "kind": { "name": "Legend", "slug": "legend", "status": "active", "canonId": "31361933-3d22-4c70-bbad-0801e9fffc0c", "version": 1, "description": "Color/symbol decoder placed adjacent to a chart or diagram." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:22.604+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "ebe00048-48bd-4302-9eb2-d50547604b53", "parentComponentId": null }, { "bbox": null, "kind": "metric", "text": "Likelihood of partnering", "attrs": null, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": { "name": "Quantification", "slug": "quantification", "status": "active", "bestFor": null, "canonId": "019dd9e1-47ab-72ce-a079-aab1f5299e88", "version": 1, "bodyDocId": null, "description": "Translating a claim into numbers, charts, or tables.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": "primary", "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-24 13:18:28+00", "model": "or:google/gemini-3.1-flash-lite-preview", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd951-c7ca-701b-9cc7-539e6c4c300c", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.85, "x": 0.038, "y": 0.06 }, "kind": "title", "text": "Global biopharmas still show high interest to partner with Chinese companies for product commercialization, more so than for clinical research, development and manufacturing", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:22.604+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "6099cc0b-2984-4b65-8af8-05a95e418025", "parentComponentId": null }, { "bbox": { "h": 0.03, "w": 0.5, "x": 0.038, "y": 0.22 }, "kind": "title", "text": "Likelihood of partnering with Chinese companies in next three years after the US BIOSECURE Act *", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Subtitle", "slug": "subtitle", "status": "active", "canonId": "019de52c-fb09-739d-900c-815b0d9ac526", "version": 1, "description": null }, "framework": null }, "subkind": "subtitle", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:22.604+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "909e3130-bc69-4632-acb5-fc3fa9a6dbdb", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [ { "to": 10, "arc": { "name": "The Consultant's Gambit", "slug": "consultants-gambit", "status": "active", "bestFor": "Business cases, project proposals, strategic recommendations", "canonId": "019dd956-5e0a-73c8-b305-81c38c959e9c", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Situation & Context -> Problem & Complication -> Solution & Approach -> Evidence & Proof -> Impact & Next Steps", "description": null, "familyLabel": null }, "from": 6, "name": "Evidence & Proof", "beatId": "f22e8876-c901-4ea3-b100-be2f21d5e929", "matchId": "382efbae-e1f6-4e39-8b56-a2b69643d386", "beatType": { "name": "Evidence & Proof", "slug": "consultants-gambit-evidence-proof", "status": "active", "canonId": "019dd9b8-07b1-7688-8e1e-7637fec3802a", "version": 1, "description": null }, "evidence": "The document presents data and findings from L.E.K.'s survey", "position": 2, "isPrimaryArc": true, "parentBeatType": { "name": "Evidence", "slug": "evidence", "status": "active", "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a", "version": 1, "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development." }, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [ { "to": 10, "from": 4, "loop": { "name": "27_cost_of_inaction", "slug": "27-cost-of-inaction", "status": "active", "bestFor": "Urgent budget requests, compliance, risk mitigation", "canonId": "019dd956-70d1-7395-a15b-857ba858b394", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "description": "Quantify what happens if the audience does nothing", "familyLabel": null }, "matchId": "04a5278d-7e5b-4b55-a8c7-0de1c16bfa6b", "evidence": "The document presents data on the potential impact of the Act on partnerships with Chinese companies", "position": 0, "objective": "Highlighting the consequences of not adapting to the US BIOSECURE Act", "confidence": 0.6, "extraction": { "at": "2026-07-16 21:06:12.966727+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 11, "type": "appendix", "title": "The slide uses a matrix-like structure to show vertical industry sectors and horizontal functional capabilities.", "function": "present_framework", "rawType": "other", "block": null, "metadata": { "slideType": "other", "slideTypeCanon": { "name": "Other (fallback)", "slug": "other", "status": "active", "canonId": "019de52d-0af5-71ed-83de-d51ae245fc43", "version": 1, "description": null }, "function": "present_framework", "functionCanon": { "name": "Present framework", "slug": "present_framework", "status": "active", "canonId": "019de52d-1403-7667-9100-d2ac6709f750", "version": 1, "description": null }, "density": "balanced", "densityScore": 48, "componentCount": 6, "textChars": 467, "nDataPoints": 3, "notes": "The slide uses a matrix-like structure to show vertical industry sectors and horizontal functional capabilities.", "elementsJson": [ "headline_text", "icon_grid", "bullet_list" ], "confidence": 0.95, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 19:25:18.597+00", "seconds": 2.866, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-5ca1-7489-b638-229be117d58e/11", "deck": "/decks/019dd923-5ca1-7489-b638-229be117d58e", "deckAnchor": "/decks/019dd923-5ca1-7489-b638-229be117d58e#slide-11", "deckJson": "/decks/019dd923-5ca1-7489-b638-229be117d58e.json" }, "components": [ { "bbox": { "h": 0.18, "w": 0.9, "x": 0.05, "y": 0.44 }, "kind": "diagram", "text": "L.E.K. Horizontal Practices", "attrs": null, "canon": { "kind": { "name": "Diagram", "slug": "diagram", "status": "active", "canonId": "019de52c-f9f0-734a-81de-15382ff28c65", "version": 1, "description": "Schematic or relational diagram." }, "tool": null, "subkind": { "name": "Process flow", "slug": "process", "status": "active", "canonId": "019de52d-039c-718f-ad3a-efe9c4b3c838", "version": 1, "description": null }, "framework": null }, "subkind": "process", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:18.597+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "ce47a3e4-5d12-4f4b-8b2a-79050504bded", "parentComponentId": null }, { "bbox": { "h": 0.18, "w": 0.9, "x": 0.05, "y": 0.24 }, "kind": "diagram", "text": "L.E.K. Vertical Practices", "attrs": null, "canon": { "kind": { "name": "Diagram", "slug": "diagram", "status": "active", "canonId": "019de52c-f9f0-734a-81de-15382ff28c65", "version": 1, "description": "Schematic or relational diagram." }, "tool": null, "subkind": { "name": "Value chain", "slug": "value-chain", "status": "active", "canonId": "019de52d-048a-769c-aad6-4abdde7ef317", "version": 1, "description": null }, "framework": null }, "subkind": "value-chain", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:18.597+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "8aad8500-e306-4354-a736-f9f1269c8a08", "parentComponentId": null }, { "bbox": { "h": 0.06, "w": 0.08, "x": 0.88, "y": 0.9 }, "kind": "image", "text": "L.E.K. Consulting Logo", "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Logo", "slug": "logo", "status": "active", "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302", "version": 1, "description": null }, "framework": null }, "subkind": "logo", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:18.597+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "3bae1f22-1d7c-4d80-9bd8-6934b2da66cb", "parentComponentId": null }, { "bbox": { "h": 0.25, "w": 0.8, "x": 0.05, "y": 0.66 }, "kind": "list", "text": "Approximately 75 full-time healthcare-focused Managing Directors globally; Hundreds of dedicated consulting staff; Global network of 10,000+ healthcare industry executives; Hundreds of projects per year; Industry-leading thought leadership; Leading advisor.", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:18.597+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "98905d57-a995-4792-b67f-31f53eeb47c1", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.9, "x": 0.05, "y": 0.08 }, "kind": "title", "text": "L.E.K. covers all parts of the healthcare ecosystem with deep expertise across all major practice areas", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:18.597+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "ad1bb9cf-13b9-4a26-b398-6f668c947eeb", "parentComponentId": null }, { "bbox": { "h": 0.03, "w": 0.3, "x": 0.05, "y": 0.16 }, "kind": "title", "text": "L.E.K. Healthcare Sector Overview", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Subtitle", "slug": "subtitle", "status": "active", "canonId": "019de52c-fb09-739d-900c-815b0d9ac526", "version": 1, "description": null }, "framework": null }, "subkind": "subtitle", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:18.597+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "3eb79fa7-8077-4b1a-a167-87d9c9fddf8f", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [ { "matchId": "bcca2b77-d455-46c8-9f7f-80175a5986b3", "evidence": "The slide maps vertical industry sectors against horizontal functional capabilities.", "framework": null, "confidence": 0.8, "extraction": { "at": "2026-05-02 19:25:18.597+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 11, "frameworkName": "value-chain" } ], "arcBeats": [ { "to": 12, "arc": { "name": "The Consultant's Gambit", "slug": "consultants-gambit", "status": "active", "bestFor": "Business cases, project proposals, strategic recommendations", "canonId": "019dd956-5e0a-73c8-b305-81c38c959e9c", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Situation & Context -> Problem & Complication -> Solution & Approach -> Evidence & Proof -> Impact & Next Steps", "description": null, "familyLabel": null }, "from": 11, "name": "Impact & Next Steps", "beatId": "0238f363-ad64-4a16-9a67-df99117320f1", "matchId": "382efbae-e1f6-4e39-8b56-a2b69643d386", "beatType": { "name": "Impact & Next Steps", "slug": "consultants-gambit-impact-next-steps", "status": "active", "canonId": "019dd9b8-0849-7728-9ee9-fd1609c4c655", "version": 1, "description": null }, "evidence": "The document provides insights into strategic adjustments and future implications", "position": 3, "isPrimaryArc": true, "parentBeatType": { "name": "Resolution", "slug": "resolution", "status": "active", "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b", "version": 1, "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution." }, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [], "locked": true }, { "page": 12, "type": "appendix", "function": "other", "rawType": "other", "block": null, "metadata": { "slideType": "other", "slideTypeCanon": { "name": "Other (fallback)", "slug": "other", "status": "active", "canonId": "019de52d-0af5-71ed-83de-d51ae245fc43", "version": 1, "description": null }, "function": "other", "functionCanon": { "name": "Other (fallback)", "slug": "other", "status": "active", "canonId": "019de52d-15e1-75bc-99dc-07732380e2ce", "version": 1, "description": null }, "density": "sparse", "densityScore": 13, "componentCount": 4, "textChars": 106, "nDataPoints": 0, "notes": null, "elementsJson": [ "headshot", "map", "icon_grid" ], "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 19:25:18.25+00", "seconds": 2.181, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-5ca1-7489-b638-229be117d58e/12", "deck": "/decks/019dd923-5ca1-7489-b638-229be117d58e", "deckAnchor": "/decks/019dd923-5ca1-7489-b638-229be117d58e#slide-12", "deckJson": "/decks/019dd923-5ca1-7489-b638-229be117d58e.json" }, "components": [ { "bbox": { "h": 0.35, "w": 0.43, "x": 0.535, "y": 0.25 }, "kind": "image", "text": "Global office locations map", "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Map", "slug": "map", "status": "active", "canonId": "019de52c-fe4d-77bd-b0a4-d72d58b9e5a4", "version": 1, "description": null }, "framework": null }, "subkind": "map", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:18.25+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "be9f6c90-cab8-467c-9b60-176f00c68d1b", "parentComponentId": null }, { "bbox": { "h": 0.6, "w": 0.45, "x": 0.038, "y": 0.22 }, "kind": "list", "text": "List of 6 partners with contact details", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:18.25+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "2c40e24d-3a7a-4512-a449-937ec2cc2b35", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.3, "x": 0.6, "y": 0.7 }, "kind": "other", "text": "Contact icons and QR code", "attrs": null, "canon": { "kind": { "name": "Other", "slug": "other", "status": "active", "canonId": "019de52c-fa90-743c-8bf6-20d1fbe82b6d", "version": 1, "description": "Fallback when no canonical kind applies." }, "tool": null, "subkind": { "name": "Unclassified", "slug": "unclassified", "status": "active", "canonId": "019de52d-05ca-77db-81fb-db7d4234bbc0", "version": 1, "description": null }, "framework": null }, "subkind": "unclassified", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:18.25+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "b04b90bf-dcb5-41ba-b0ae-aacf30e86412", "parentComponentId": null }, { "bbox": { "h": 0.035, "w": 0.183, "x": 0.038, "y": 0.105 }, "kind": "title", "text": "Connect with us", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:18.25+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "f4d7cbb8-da43-4cfe-b7ad-b3c8e4c941be", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [ { "to": 12, "arc": { "name": "The Consultant's Gambit", "slug": "consultants-gambit", "status": "active", "bestFor": "Business cases, project proposals, strategic recommendations", "canonId": "019dd956-5e0a-73c8-b305-81c38c959e9c", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Situation & Context -> Problem & Complication -> Solution & Approach -> Evidence & Proof -> Impact & Next Steps", "description": null, "familyLabel": null }, "from": 11, "name": "Impact & Next Steps", "beatId": "0238f363-ad64-4a16-9a67-df99117320f1", "matchId": "382efbae-e1f6-4e39-8b56-a2b69643d386", "beatType": { "name": "Impact & Next Steps", "slug": "consultants-gambit-impact-next-steps", "status": "active", "canonId": "019dd9b8-0849-7728-9ee9-fd1609c4c655", "version": 1, "description": null }, "evidence": "The document provides insights into strategic adjustments and future implications", "position": 3, "isPrimaryArc": true, "parentBeatType": { "name": "Resolution", "slug": "resolution", "status": "active", "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b", "version": 1, "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution." }, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [], "locked": true }, { "page": 13, "type": "setup", "function": "front_matter", "rawType": "disclaimer", "block": null, "metadata": { "slideType": "disclaimer", "slideTypeCanon": { "name": "Disclaimer", "slug": "disclaimer", "status": "active", "canonId": "019de52d-0801-727b-b98a-5ed095aeee78", "version": 1, "description": null }, "function": "front_matter", "functionCanon": { "name": "Front matter", "slug": "front_matter", "status": "active", "canonId": "019de52d-133d-73f0-9e26-201eda96b098", "version": 1, "description": null }, "density": "sparse", "densityScore": 15, "componentCount": 3, "textChars": 259, "nDataPoints": 0, "notes": null, "elementsJson": [ "headline_text", "paragraph", "logo_grid" ], "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 19:25:21.432+00", "seconds": 5.15, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-5ca1-7489-b638-229be117d58e/13", "deck": "/decks/019dd923-5ca1-7489-b638-229be117d58e", "deckAnchor": "/decks/019dd923-5ca1-7489-b638-229be117d58e#slide-13", "deckJson": "/decks/019dd923-5ca1-7489-b638-229be117d58e.json" }, "components": [ { "bbox": { "h": 0.55, "w": 0.86, "x": 0.07, "y": 0.25 }, "kind": "disclaimer", "text": "This document is intended to provide information and is for illustration purposes only. It cannot be relied upon by any recipient. L.E.K. shall not be liable for any loss, damage or expense. Forward-looking statements are not guaranteed.", "attrs": null, "canon": { "kind": { "name": "Disclaimer", "slug": "disclaimer", "status": "active", "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc", "version": 1, "description": "Legal/cautionary text that occupies most of the body of its slide." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:21.432+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "1dd2a330-42d3-48a5-9f11-e193914c4233", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.07, "x": 0.88, "y": 0.9 }, "kind": "image", "text": "L.E.K.", "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Logo", "slug": "logo", "status": "active", "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302", "version": 1, "description": null }, "framework": null }, "subkind": "logo", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:21.432+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "ea20e844-ddf5-486e-bb2d-41d8c8117e08", "parentComponentId": null }, { "bbox": { "h": 0.03, "w": 0.15, "x": 0.07, "y": 0.1 }, "kind": "title", "text": "Important notice", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:25:21.432+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "aa651958-b773-4d3e-a152-0dfcd32a65fb", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [], "locked": true } ], "arcBeats": [ { "from": 1, "to": 3, "label": "Situation & Context", "description": "The document provides an overview of the US BIOSECURE Act and its context" }, { "from": 4, "to": 5, "label": "Problem & Complication", "description": "The document highlights the potential impact of the Act on biopharmas and contract services" }, { "from": 6, "to": 10, "label": "Evidence & Proof", "description": "The document presents data and findings from L.E.K.'s survey" }, { "from": 11, "to": 12, "label": "Impact & Next Steps", "description": "The document provides insights into strategic adjustments and future implications" } ], "loops": [ { "from": 4, "to": 10, "label": "Cost Of Inaction", "description": "Highlighting the consequences of not adapting to the US BIOSECURE Act" } ] }